Biblio

Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Christopeit, M., Labopin, M., Gorin, N.-C., Saraceni, F., Passweg, J., Forcade, E., Maertens, J., van Lint, M.Teresa, Bosi, A., Niederwieser, D., et al. (2018). Allogeneic Stem Cell Transplantation following Relapse post Autologous Stem Cell Transplantation in adult patients with Acute Myeloid Leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.Am J Hematol.
Hangai, M., Urayama, K.Y., Tanaka, J., Kato, K., Nishiwaki, S., Koh, K., Noguchi, M., Kato, K., Yoshida, N., Sato, M., et al. (2019). Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults.Biol Blood Marrow Transplant.
Hangai, M., Urayama, K.Y., Tanaka, J., Kato, K., Nishiwaki, S., Koh, K., Noguchi, M., Kato, K., Yoshida, N., Sato, M., et al. (2019). Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults.Biol Blood Marrow Transplant.
Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
Krüger, W.H., Hirt, C., Basara, N., Sayer, H.G., Behre, G., Fischer, T., Grobe, N., Maschmeyer, G., Niederwieser, D., and Dölken, G. (2014). Allogeneic stem cell transplantation for mantle cell lymphoma-final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO).Ann Hematol.
Blaise, D., Nguyen, S., Bay, J.-O., Chevallier, P., Contentin, N., Dhédin, N., Duléry, R., Eliaou, J.-F., Rubio, M.-T., Suarez, F., et al. (2014). [Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1).].Pathol Biol (Paris).
Jaimes-Albornoz, D., Mannone, L., Nguyen-Quoc, S., Chalandon, Y., Chevallier, P., Mohty, M., Meunier, M., Robin, M., Ledoux, M.-P., Guillerm, G., et al. (2019). Allogeneic stem cell transplantation in therapy-related myelodysplasia after autologous transplantation for lymphoma: a retrospective study of the SFGM-TC.Biol Blood Marrow Transplant.
Herrera, A.F., Chen, L., Khajavian, S., Chase, M., Darrah, J., Maloney, D., Ho, V.T., Soiffer, R.J., Antin, J.H., Forman, S.J., et al. (2019). Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-cell Lymphoma.Biol Blood Marrow Transplant.
Wolach, O., Stevenson, K.E., Wadleigh, M., DeAngelo, D.J., Steensma, D.P., Ballen, K.K., Soiffer, R.J., Antin, J.H., Neuberg, D.S., Ho, V.T., et al. (2016). Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission.Am J Hematol.
Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T., Okada, K., Shiba, N., Sakamoto, K., et al. (2016). Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.Nature.
Lachowiez, C., Cook, R.J., Hayes-Lattin, B., Maziarz, R.T., Borate, U., Traer, E., Leonard, J., Newell, L., Dao, K.-H., and Meyers, G. (2019). Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.Hematol Oncol Stem Cell Ther.
Veltri, L., Rezvani, K., Oran, B., Mehta, R., Rondon, G., Kebriaei, P., Popat, U., Nieto, Y., Hosing, C., Qazilbash, M., et al. (2018). Allotransplants for patients 65 years or older with high-risk acute myeloid leukemia.Biol Blood Marrow Transplant.
Newman, R.G., Ross, D.B., Barreras, H., Herretes, S., Podack, E.R., Komanduri, K.V., Perez, V.L., and Levy, R.B. (2013). The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.Immunol Res.
Tabolacci, C., Cordella, M., Turcano, L., Rossi, S., Lentini, A., Mariotti, S., Nisini, R., Sette, G., Eramo, A., Piredda, L., et al. (2015). Aloe-emodin exerts a potent anticancer and immunomodulatory activity on BRAF-mutated human melanoma cells.Eur J Pharmacol.
Noguchi, F., Nakajima, T., Inui, S., Reddy, J.K., and Itami, S. (2014). Alteration of Skin Wound Healing in Keratinocyte-Specific Mediator Complex Subunit 1 Null Mice.Plos One9, e102271.
Noguchi, F., Nakajima, T., Inui, S., Reddy, J.K., and Itami, S. (2014). Alteration of Skin Wound Healing in Keratinocyte-Specific Mediator Complex Subunit 1 Null Mice.Plos One9, e102271.
Bursch, F., Kalmbach, N., Naujock, M., Staege, S., Eggenschwiler, R., Abo-Rady, M., Japtok, J., Guo, W., Hensel, N., Reinhardt, P., et al. (2019). Altered calcium dynamics and glutamate receptor properties in iPSC derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.Hum Mol Genet.
Martínez-Ramírez, C., Baraibar, A.M., Nanclares, C., Méndez-López, I., Gómez, A., Muñoz, M.P., de Diego, A.M.G., Gandía, L., Casarejos, M.José, and García, A.G. (2018). Altered excitability and exocytosis in chromaffin cells from the R6/1 mouse model of Huntington's disease is linked to overexpression of mutated huntingtin.J Neurochem.
Capetian, P., Stanslowsky, N., Bernhardi, E., Grütz, K., Domingo, A., Brüggemann, N., Naujock, M., Seibler, P., Klein, C., and Wegner, F. (2018). Altered glutamate response and calcium dynamics in iPSC-derived striatal neurons from XDP patients.Exp Neurol.
Wu, J., Okamura, D., Li, M., Suzuki, K., Luo, C., Ma, L., He, Y., Li, Z., Benner, C., Tamura, I., et al. (2015). An alternative pluripotent state confers interspecies chimaeric competency.Nature.
Medina, M.A., Ugarte, G.D., Vargas, M.F., Avila, M.E., Necuñir, D., Elorza, A.A., Gutiérrez, S.E., and De Ferrari, G.V. (2015). Alternative RUNX1 Promoter Regulation by Wnt/β-Catenin Signaling in Leukemia Cells and Human Hematopoietic Progenitors.J Cell Physiol.
Kazantseva, J., Kivil, A., Tints, K., Kazantseva, A., Neuman, T., and Palm, K. (2013). Alternative Splicing Targeting the hTAF4-TAFH Domain of TAF4 Represses Proliferation and Accelerates Chondrogenic Differentiation of Human Mesenchymal Stem Cells.Plos One8, e74799.
Ferreira, C.R., Jarmusch, A.K., Pirro, V., Alfaro, C.M., González-Serrano, A.F., Niemann, H., Wheeler, M.B., Rabel, R.A.C., Hallett, J.E., Houser, R., et al. (2015). Ambient ionisation mass spectrometry for lipid profiling and structural analysis of mammalian oocytes, preimplantation embryos and stem cells.Reprod Fertil Dev.
Mar, J., Nagalingam, N., Song, Y., Onizawa, M., Lee, J.-W., and Lynch, S. (2014). Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition .Gut Microbes5.
Browne, J.A., Nho, S.J., Goodman, S.B., and Valle, C.J.Della (2019). American Association of Hip and Knee Surgeons, Hip Society, and Knee Society Position Statement on Biologics for Advanced Hip and Knee Arthritis.J Arthroplasty.

Pages